Dentsply Sirona (XRAY)
(Delayed Data from NSDQ)
$14.30 USD
-0.01 (-0.07%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $14.28 -0.02 (-0.14%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, DENTSPLY SIRONA Inc. has a PEG ratio of 1.15 compared to the Medical - Dental Supplies industry's PEG ratio of 1.54.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
XRAY 14.30 -0.01(-0.07%)
Will XRAY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for XRAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XRAY
Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Align Technology (ALGN) Q2 Earnings and Revenues Lag Estimates
XRAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Dentsply International (XRAY) is a Strong Momentum Stock
Here's Why Dentsply International (XRAY) is a Strong Value Stock
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Other News for XRAY
Heartland Small Cap Value Strategy Q2 2025 Commentary
Dentsply Sirona (XRAY) Stock Outlook: Analyst Maintains Outperform Rating | XRAY Stock News
Needham Reiterates Hold Rating on Dentsply Sirona (XRAY) | XRAY Stock News
Roth bullish on Globus Medical amid CEO Transition, solid pre-reported results
Dentsply Sirona (XRAY) Appoints New CEO, Reaffirms 2025 Outlook